These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6891594)

  • 21. Distribution and elimination of RGH-5002 in rats.
    Terjéki E; Pátfalusi M; Trafikánt G; Kapás M
    Acta Physiol Hung; 1995; 83(2):143-50. PubMed ID: 8588501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of amezinium in rat and dog.
    Traut M; Brode E; Neumann B; Kummer H
    Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-FU uptake in liver metastases after intravenous and intraperitoneal administration: an autoradiographic study in the rat.
    Mahteme H; Larsson BS; Sundin A; Graf W
    Anticancer Res; 1998; 18(2A):943-9. PubMed ID: 9615745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition of low doses of 14C-bisphenol A in male, female, pregnant, fetal, and neonatal rats.
    Kurebayashi H; Nagatsuka S; Nemoto H; Noguchi H; Ohno Y
    Arch Toxicol; 2005 May; 79(5):243-52. PubMed ID: 15902421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption, distribution and excretion of DL-gamma-amino-beta-hydroxybutyric acid-1-14C (GABOB-1-14C) in the rat.
    Bonardi G; Mondino A; Silvestri S; Zanolo G
    Arzneimittelforschung; 1981; 31(11):1910-3. PubMed ID: 7198473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of the opioid antagonist, LY255582, in rats and dogs.
    Swanson SP; Catlow J; Pohland RC; Chay SH; Johnson T
    Drug Metab Dispos; 1995 Sep; 23(9):916-21. PubMed ID: 8565781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
    Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
    Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.
    Stendel R; Scheurer L; Schlatterer K; Stalder U; Pfirrmann RW; Fiss I; Möhler H; Bigler L
    Clin Pharmacokinet; 2007; 46(6):513-24. PubMed ID: 17518510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tissue distribution of 14C-tetroxoprim in the rat (author's transl)].
    Vergin H
    Arzneimittelforschung; 1980; 30(2):309-13. PubMed ID: 7378110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolic disposition of an orally active pyridyl thiadiazinone cardiotonic agent (MPTD) in rat and baboon.
    McKillop D; Pickup KJ; Swaisland AJ; Holmes BF
    Xenobiotica; 1990 Apr; 20(4):401-15. PubMed ID: 2346037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
    Timchalk C; Smith FA; Bartels MJ
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absorption, distribution, elimination and metabolism of 14C-heptaminol hydrochloride in rat.
    Chanoine F; Benedetti MS; Ancher JF; Dostert P
    Arzneimittelforschung; 1981; 31(9):1430-5. PubMed ID: 7197949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
    Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon.
    Cameron BD; Draffan GH; Dunsire JP; Zimmer A
    Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.
    Cho YB; Kim KH; Kim DK
    Drug Metab Dispos; 1995 Nov; 23(11):1280-5. PubMed ID: 8591731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The pharmacokinetics of Z-2-amino-5-chlorobenzophenoneamidinohydrazone in the rat].
    Schieweck A; offchert HH; Morgenroth U; Joram U
    Pharmazie; 1993 May; 48(5):370-3. PubMed ID: 8327566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Local chemotherapy of osteitis with 4% taurolin-gel].
    Lob G; Burri C
    Fortschr Med; 1983 Jan; 101(3):88-93. PubMed ID: 6826138
    [No Abstract]   [Full Text] [Related]  

  • 40. [Spectrum of indications and perioperative management in i. v. port-a-cath explantation--alternative administration of taurolin in case of i. v. port-a-cath infection].
    Weber M; Meyer F; Halloul Z
    Zentralbl Chir; 2009 Aug; 134(4):350-6. PubMed ID: 19688684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.